Drug Coverage
Drug Coverage
Navigating Drug Formularies
Schaeffer experts evaluate trends in drug formularies and utilization restrictions to determine whether patients are getting access to high-value medicines.
Related Topics
Top Drug Coverage Stories View All
News
Conflicts of Interest on CDC Vaccine Panel Were at Historic Lows Before RFK Jr. Dismissal
Featured Experts: Genevieve P. Kanter
In The News View All
STAT
Joyce explains why Trump could more easily use Medicare negotiations, rather than most-favored nation, to slash drug prices
Featured Experts: Geoffrey Joyce
Reuters
As insurers cut back on GLP-1 coverage, Peters says some patients are stretching doses
Featured Experts: Anne Peters
Associated Press
Joyce debunks President Trump’s claims that drugmakers are preparing to cut prices by 1,500 percent
Featured Experts: Geoffrey Joyce
Reuters
Padula provides insight on how rare disease therapies are influencing new drug pricing trends
Featured Experts: William Padula
STAT
Expanded coverage of GLP-1s is “probably the single most effective policy” for improving public health, Goldman says
Featured Experts: Dana Goldman
Featured Perspective
A Missed Chance to Make America Healthier and Richer
Medicare should revisit its decision not to broadly cover anti-obesity medications, considering the enormous value expanded access would generate for society.
Experts: Alison Sexton Ward, Dana Goldman
Drug Coverage
Experts
Featured Research
Medicare Part D Plans Increased Restrictions on Drug Coverage
Medicare Part D plans excluded more compounds from coverage or subjected more of them to review before patients can access treatments, USC researchers found.
Experts: Geoffrey Joyce, Karen Van Nuys
